Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 2502-2511, December 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pilch, Y. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pilch, Y. H.

The Antigenicity and Immunogenicity of Cell-free Extracts of Chemically Induced Murine Sarcomas

Yosef H. Pilch

Surgery Branch, National Cancer Institute, NIH, Bethesda, Maryland 20014

The induction of antitumor isoimmunity to an ethiodolinduced fibrosarcoma in female BALB/c mice and to a methylcholanthrene-induced fibrosarcoma (MC 1) in female C3H/HeN mice was accomplished using three different cell-free extracts of tumor tissue, a saline extract and two different fluorocarbon-treated extracts. The degree of immunity observed was dependent upon the length and intensiveness of the course of immunization, the route of immunization, and the size of the challenge tumor-cell inoculum. The presence of a circulating antibody of low titer was detected in immunized animals exhibiting significant tumor immunity. This antibody was not demonstrable in control animals or in immunized animals in which no significant immunity was observed. Animals immunized with extracts of normal BALB/c or C3H/HeN tissues did not exhibit increased resistance to tumor transplants. BALB/c mice rendered immune to one ethiodol-induced sarcoma displayed no increased resistance to transplants of another ethiodol-induced sarcoma arising in another mouse of the same strain. C3H/HeN mice immune to challenge with MC 1 cells exhibited no increased resistance to transplants of a breast carcinoma (Sp 1) which arose in a mouse of the same strain. Antibodies detected to the MC 1 tumor in C3H/HeN mice did not cross-react with antigens from the Sp 1 tumor. Both the immunity produced and the antibodies detected were shown to persist for at least 4.5 months.

Received 9/ 8/67. Accepted 8/ 7/68.




This article has been cited by other articles:


Home page
ScienceHome page
U. Kim
Metastasizing Mammary Carcinomas in Rats: Induction and Study of Their Immunogenicity
Science, January 2, 1970; 167(3914): 72 - 74.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.